Axcella Health Inc.
AXLADelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted in 2023; its insiders filed their last Form 4 on Mar 3, 2023; 30 institutions reported holding it in 13F filings for Q2 2023, worth $10.5M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Axcella Health Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −6 vs. Q1 2021
- Shares held
- 24.3M
- −1.29M (−5.1%) vs. Q1 2021
- Total value
- $97.3M
- −$24.4M (−20.0%) vs. Q1 2021
- New holders
- 8
- 6 more added
- Sold out
- 14
- 18 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $32 |
| Q3 2023 | 1 | $835 |
| Q2 2023 | 30 | $10.5M |
| Q1 2023 | 29 | $28.8M |
| Q4 2022 | 35 | $15.9M |
| Q3 2022 | 34 | $58.3M |
| Q2 2022 | 34 | $69.2M |
| Q1 2022 | 38 | $87.0M |
| Q4 2021 | 35 | $50.4M |
| Q3 2021 | 35 | $71.6M |
| Q2 2021 | 38 | $97.3M |
| Q1 2021 | 44 | $121.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Axcella Health Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 12,548,414 | $50.3M | 0.64% | 00.0% | Unchanged |
| FMR LLC | 5,658,365 | $22.7M | 0.00% | +4,800+0.1% | Added |
| HarbourVest Partners LLC | 2,807,981 | $11.3M | 1.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 909,389 | $3.65M | 0.00% | −75,591−7.7% | Reduced |
| Artal Group S.A. | 712,500 | $2.86M | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 297,286 | $1.19M | 0.00% | −743,690−71.4% | Reduced |
| Renaissance Technologies LLC | 158,202 | $634.0K | 0.00% | +89,115+129.0% | Added |
| Bridgeway Capital Management, LLC | 137,967 | $553.0K | 0.01% | −24,500−15.1% | Reduced |
| Geode Capital Management, LLC | 136,883 | $548.0K | 0.00% | −93,802−40.7% | Reduced |
| Zacks Investment Management | 118,469 | $475.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 117,443 | $471.0K | 0.00% | −6,843−5.5% | Reduced |
| Millennium Management LLC | 92,688 | $372.0K | 0.00% | +79,049+579.6% | Added |
| Marshall Wace, LLP | 72,422 | $290.0K | 0.00% | +17,287+31.4% | Added |
| State Street Corp | 70,676 | $283.0K | 0.00% | −153,426−68.5% | Reduced |
| Ergoteles LLC | 64,015 | $257.0K | 0.01% | +64,015 | New |
| Acadian Asset Management LLC | 46,988 | $189.0K | 0.00% | −20,748−30.6% | Reduced |
| First Trust Advisors LP | 45,013 | $181.0K | 0.00% | −1,400−3.0% | Reduced |
| HRT Financial LP | 43,894 | $176.0K | 0.00% | +43,894 | New |
| Bank of New York Mellon Corp | 43,572 | $175.0K | 0.00% | −42,196−49.2% | Reduced |
| Cutter & CO Brokerage, Inc. | 35,300 | $142.0K | 0.03% | +35,300 | New |
| Northern Trust Corp | 35,158 | $141.0K | 0.00% | −139,359−79.9% | Reduced |
| ExodusPoint Capital Management, LP | 33,424 | $134.0K | 0.00% | +33,424 | New |
| Edgewood Management LLC | 25,000 | $100.0K | 0.00% | +25,000 | New |
| TownSquare Capital, LLC | 11,950 | $52.0K | 0.00% | +11,950 | New |
| Charles Schwab Investment Management Inc | 10,305 | $42.0K | 0.00% | −20,823−66.9% | Reduced |
| HighTower Advisors, LLC | 10,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,765 | $27.0K | 0.00% | −955−12.4% | Reduced |
| Royal Bank of Canada | 4,593 | $18.0K | 0.00% | +3,075+202.6% | Added |
| Bank of America Corp | 3,330 | $13.0K | 0.00% | −18,164−84.5% | Reduced |
| Barclays PLC | 3,175 | $13.0K | 0.00% | −9,769−75.5% | Reduced |
| Morgan Stanley | 2,399 | $9.00K | 0.00% | +2,242+1,428.0% | Added |
| First Manhattan Co | 2,000 | $8.00K | 0.00% | +2,000 | New |
| JPMorgan Chase & Co | 1,580 | $7.00K | 0.00% | −28,410−94.7% | Reduced |
| Wells Fargo & Company | 1,114 | $4.00K | 0.00% | −4,744−81.0% | Reduced |
| BNP Paribas Arbitrage, SA | 411 | $1.65K | 0.00% | −1,420−77.6% | Reduced |
| American Portfolios Advisors | 400 | $1.60K | 0.00% | +400 | New |
| Global Retirement Partners, LLC | 180 | $1.00K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 109 | $0 | 0.00% | −10,891−99.0% | Reduced |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −129,108−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −64,749−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −44,901−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −22,760−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,769−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −10,150−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −9,609−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −9,025−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,562−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,541−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,126−100.0% | Sold out |
| Hoover Financial Advisors, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −505−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −145−100.0% | Sold out |